Non-invasive Advantage Target hospitals, wound care centers, and IDNs with SANUWAVE's UltraMIST system, emphasizing its non-invasive, low-pain profile and quick in-clinic use to improve patient outcomes and clinic throughput.

Reimbursement Tailwinds Q1 2026 results show revenue growth as the advanced wound care market recovers from reimbursement changes affecting skin substitutes, signaling potential payer-driven uptake and near-term demand rebound.

Consumables Growth Rising consumables utilization indicates recurring revenue potential, so focus on upselling disposables and related materials alongside the UltraMIST system to improve margins and per-site spend.

Strategic Partnerships Leverage traction with hospitals and wound care programs by offering education, training, and pilots to accelerate procurement; leverage Q1 momentum and FDA-approved technology to shorten sales cycles.

Digital Channel Expansion Use existing ecommerce and analytics infrastructure to reach clinics, home health, and DME providers; enable scalable direct-to-facility sales and service offerings with a lean sales team.